Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit A Nationwide Population-Based Study

Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit A Nationwide Population-Based Study

01 Feb 2023 6:42 PM | Michele O'Bright (Administrator)

Defize, Ingmar L. MD*,†; Goense, Lucas MD, PhD*; Borggreve, Alicia S. MD, PhD*; Mook, Stella MD, PhD†; Meijer, Gert J. PhD†; Ruurda, Jelle P. MD, PhD*; van Hillegersberg, Richard MD, PhD*; on behalf of the Dutch Upper GI Cancer Audit Group

Read Abstract:  Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit A Nationwide Population-Based Study

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software